×
About 9,435 results

ALLMedicine™ Eczema Center

Research & Reviews  2,459 results

Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the ...
https://doi.org/10.1097/DER.0000000000000795
Dermatitis : Contact, Atopic, Occupational, Drug; Chovatiya R, Begolka WS et. al.

Sep 14th, 2021 - Atopic dermatitis (AD) is associated with substantial financial cost, including increased out-of-pocket (OOP) expenses. Associations and impact of OOP cost are poorly understood. The aim of the study was to characterize the impact and associations...

Should atopic dermatitis patients starting JAK inhibitors take prophylactic acyclovir?
https://doi.org/10.1080/09546634.2021.1978665
The Journal of Dermatological Treatment; Shah MA, Beuerlein KG et. al.

Sep 9th, 2021 - JAK inhibitors are cytokine modulators that are effective in the treatment of numerous autoimmune diseases. However, given their immunosuppressive effects, they may, at least potentially, increase the risk of severe herpes infection in individuals...

A Three Arms Non-randomized Trial Investigating Measures for Bioaerosol Reduction in the Salmon Industry
https://clinicaltrials.gov/ct2/show/NCT05039229

Sep 9th, 2021 - The intervention trial is part of a broader study on assessment of exposure and health of workers in the salmon industry. Measurements of exposure, health examinations and questionnaire data serve as a basis for both intervention- and other substu...

Quality of life for children with allergic skin diseases.
https://doi.org/10.2174/1573396317666210901124211
Current Pediatric Reviews; Hon KL, Chu S et. al.

Sep 8th, 2021 - Allergic skin diseases are highly prevalent among children. Patients with allergic skin diseases experience sociopsychological and quality-of-life (QoL) burdens in excess of those in the general population. Children and their caregivers are especi...

Oral once a day treatment for eczema.
https://doi.org/10.1136/archdischild-2021-323093
Archives of Disease in Childhood;

Sep 4th, 2021 - Oral once a day treatment for eczema.|2021||

see more →

Guidelines  4 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) ...
https://doi.org/10.1111/jdv.14891
Journal of the European Academy of Dermatology and Venere... Wollenberg A, Barbarot S et. al.

Apr 21st, 2018 - This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a consensus-based guideline, taking available evidence from other guidelines, systematic revi...

BSACI guideline for the diagnosis and management of peanut and tree nut allergy.
https://doi.org/10.1111/cea.12957
Clinical and Experimental Allergy : Journal of the Britis... Stiefel G, Anagnostou K et. al.

Aug 25th, 2017 - Peanut nut and tree nut allergy are characterised by IgE mediated reactions to nut proteins. Nut allergy is a global disease. Limited epidemiological data suggest varying prevalence in different geographical areas. Primary nut allergy affects over...

Guideline for the management of wounds in patients with lower-extremity venous disease:...
https://doi.org/10.1097/WON.0b013e31827179e9
Journal of Wound, Ostomy, and Continence Nursing : Offici... Kelechi TJ, Johnson JJ et. al.

Nov 10th, 2012 - This article provides an executive summary of the lower extremity venous disease (LEVD) evidence-based guideline produced by the WOCN Wound Guidelines Task Force. The target audience for this guideline is health care professionals who specialize i...

see more →

Drugs  708 results see all →

Clinicaltrials.gov  8 results

A Three Arms Non-randomized Trial Investigating Measures for Bioaerosol Reduction in the Salmon Industry
https://clinicaltrials.gov/ct2/show/NCT05039229

Sep 9th, 2021 - The intervention trial is part of a broader study on assessment of exposure and health of workers in the salmon industry. Measurements of exposure, health examinations and questionnaire data serve as a basis for both intervention- and other substu...

Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
https://clinicaltrials.gov/ct2/show/NCT04345367

Aug 31st, 2021 - This is a randomized, double-blind, double-dummy, active-controlled, multi-center study to assess the efficacy and safety of abrocitinib 200 mg (2 x 100 mg tablets) administered orally QD compared with dupilumab 300 mg administered by subcutaneous...

Characterization of Chronic Hand Eczema
https://clinicaltrials.gov/ct2/show/NCT05026554

Aug 30th, 2021 - Prospective longitudinal study of adult patients with moderate to severe chronic hand eczema to characterize the pathophysiology of chronic hand eczema and assess changes in morphological parameters and molecular signatures with non-invasive techn...

Patient Forward Access to Clinical and Technological Research: Genetic Influences on Cancer and Atopic Dermatitis
https://clinicaltrials.gov/ct2/show/NCT04362852

Aug 13th, 2021 - Inspire will survey its members who have eczema/atopic dermatitis or have had cancer to identify patients that match the health criteria for the study including 1) a diagnosis of one of the two diseases under investigation, and 2) evidence of a fa...

Xerosis and Use of Topical Moisturizer
https://clinicaltrials.gov/ct2/show/NCT04341623

Jan 27th, 2021 - Adult subjects will be offered an opportunity to participate in the study. Subjects will have a diagnosis of xerosis in the context (current or historic) of atopic dermatitis. A total of 30 subjects will be enrolled. After consent and basic demogr...

see more →

News  592 results

AbbVie, Lilly Face Fresh Delays in FDA Approval for Expanded Use of Arthritis Drugs
https://www.medscape.com/viewarticle/954936

Jul 19th, 2021 - (Reuters) - AbbVie Inc and Eli Lilly & Co are facing fresh delays in the approval of their respective rheumatoid arthritis drugs for treating the chronic skin disease eczema as the U.S. health regulator assesses the new class of treatment over saf...

Adopt a Stepped Approach to Atopic Eczema Management
https://www.medscape.com/viewarticle/954599

Jul 13th, 2021 - Dr Caroline Ward Dr Caroline Ward, GP and standing member of the National Institute for Health and Care Excellence (NICE) Managing Common Infections Advisory Committee, discusses NICE recommendations on the treatment of atopic eczema, focusing on ...

UV Light Linked to Prevention of Allergic Disease in Infants
https://www.medscape.com/viewarticle/954650

Jul 12th, 2021 - Higher direct ultraviolet (UV) light exposure in the first 3 months of life was linked to lower incidence of proinflammatory immune markers and lower incidence of eczema in an early-stage double-blind, randomized controlled trial.   Kristina Ruete...

Survey Spotlights the Out-of-Pocket Burden on Blacks With Atopic Dermatitis
https://www.medscape.com/viewarticle/953885

Jun 28th, 2021 - Compared with their non-Black counterparts, Black patients with atopic dermatitis (AD) are significantly more likely to be younger, have lower household incomes, live in an urban setting, and use Medicaid or state assistance. They also have signif...

12-Month Follow-Up Shows Monthly Maintenance Dose of Tralokinumab Maintains Response in Some Patients With AD
https://www.medscape.com/viewarticle/953480

Jun 21st, 2021 - Dr Andrew Blauvelt A large proportion of initial Investigator Global Assessment (IGA) 0/1 or Eczema Area and Severity Index (EASI) 75 responders at week 16 maintained response with continued tralokinumab dosing every 2 weeks or every 4 weeks durin...

see more →

Patient Education  3 results see all →